Mini-puberty testosterone and infant autistic traits

Understanding autism: Causes, diagnosis, and advancing therapies

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition marked by difficulties in social communication, languages, and repetitive behaviors. Its rising prevalence has made it a critical global public health issue. ASD is believed to arise from a combination of genetic and environmental influences. While some gene mutations associated with ASD have been identified, most cases lack clear genetic explanations. Evidence increasingly points to early-life environmental factors as key contributors to ASD, including advanced parental age, maternal diabetes during pregnancy, infections, hormonal imbalances, certain medications, and exposure to air pollution. Currently, ASD diagnosis relies on behavioral assessments, but the absence of specific molecular biomarkers poses significant obstacles to early detection and targeted therapies. Encouragingly, research has identified potential biomarkers, such as neuroimaging classifiers, electroencephalography patterns, eye-tracking data, digital analytics, gene expression profiles, inflammatory and chemokine markers, proteomic and metabolomic profiles, and gut microbiota characteristics. Potential therapeutical strategies under investigation include digital therapies, non-invasive brain stimulation, antioxidants, oxytocin, AVPR1a antagonists, PPAR agonists, and mTOR inhibitors. This review explores ASD across five areas: epidemiological trends, genetic mechanisms, early-life environmental factors and their potential roles, diagnostic biomarkers, and therapeutic approaches.

Early selective attention to the articulating mouth as a potential female-specific marker of better language development in autism: a review

Autism is a neurodevelopmental condition with early onset, usually entailing language differences compared to neurotypical peers. Females are four times less likely than males to be diagnosed with autism, and the language features associated with this condition are less frequent in females than in males. However, the developmental mechanisms underlying these sex differences remain unclear. In neurotypical populations, sex differences in language development are also observable from early on, with females outperforming males. One mechanism underlying these sex differences may be early differences in selective attention to talking faces. During the first year, more mouth-looking generally predicts better language development, but sex differences exist. Female infants look at the mouth of a talking face more than males without penalizing looking to the eyes, and reduced mouth-looking in early infancy relates to better vocabulary in toddlerhood only in females. In this hypothesis and theory article, we propose that unique female gaze patterns to the mouth may constitute an early female-specific candidate marker that acts as a protective marker for language development also in autism. Since autism is highly heritable, investigating infants at elevated likelihood for autism offers the opportunity to search for sex-specific markers operating early in life before autistic features and language differences emerge. We argue that, as in neurotypical female infants, mouth-looking may also protect female infants-at-elevated-likelihood-for-autism population from potential later differences in language skills. If so, then sex-specific early behavioral markers, potentially acting as protective markers of language, may compensate for some genetic risk markers affecting this population. Here we gather evidence from neurotypical infants and those with elevated likelihood of autism to uncover why biological sex, the development of selective attention to the mouth, and language acquisition could be intimately related in both populations. We also propose hypotheses regarding potential sex-differentiated neurodevelopmental pathways. We end discussing future research challenges: how generalizable mouth-looking could be as a potential female-specific early language marker across contexts (experimental vs. real life), countries, and developmental time. Ultimately, we aim to target a novel protective candidate of language acquisition, informing tailored interventions that consider sex as an important source of individual variability.